CompletedPhase 4

Chlorzoxazone in Hip and Knee Arthroplasty

Denmark400 participantsStarted 2015-09-01

Plain-language summary

The purpose of this study is to elucidate whether patients operated with THA and TKA can benefit from treatment with chlorzoxazone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Planned primary unilateral THA or TKA * Patients (male/female) ≥ 18 år * Patients giving written informed consent and authority. * Patients receiving spinal anaesthesia Exclusion Criteria: * Patients with intolerance to trial medications * Rejection of or contraindicated spinal anaesthesia * Patients with rheumatoid arthritis. * Patients with Body Mass Index (BMI) ≥ 35 * Patients that do not read or write Danish

What they're measuring

Pain after 5 meter walk

Timeframe: 24 hours post OP

Trial details

NCT IDNCT02405104

SponsorNorthern Orthopaedic Division, Denmark

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-31

View on ClinicalTrials.gov More Osteoarthritis of Hip trials